Last reviewed · How we verify

NCT05999539

Comparison of Characteristics Between Faller and Non-faller Transtibial Amputees

Completed Last updated 26 December 2023
What this trial tests

trial testing Transtibial prosthesis in Amputation in 36 participants. Completed in 15 December 2023.

Timeline
25 August 2023
Primary endpoint
15 December 2023
15 December 2023

Quick facts

Lead sponsorEastern Mediterranean University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment36
Start date25 August 2023
Primary completion15 December 2023
Estimated completion15 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Eastern Mediterranean University

Who can join

18 and older, any sex, with Amputation or Fall. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Researchers aim to compare demographic characteristics, prosthesis type, functional capacity, and quality of life between faller and non-faller transtibial amputees.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Amputation

Currently open trials in the same condition.

Other Eastern Mediterranean University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05999539.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing